4/A: Unicycive Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4/A)
Sandeep Laumas, a Director of Unicycive Therapeutics, Inc., received 47,941 shares of common stock on May 14, 2026.
Summary
- Grant/award: acquired 47,941 Restricted Stock Units on May 14, 2026; holds 47,941 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sandeep Laumas — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-05-14 | Grant/award | Restricted Stock Units | 47,941 | — | — | 47,941 |
Key Dates
| Date | Description |
|---|---|
| 2026-05-14 | Grant/award (47,941 shares) |
Keywords
insider transaction, Form 4/A, UNCY, Unicycive Therapeutics, Inc., neutral, Sandeep Laumas
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.